SIGN UP
LOG IN
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga·06/06/2025 17:06:47
Listen to the news
Gainers
- Phathom Pharmaceuticals (NASDAQ:PHAT) stock rose 85.8% to $8.71 during Friday's regular session. The company's market cap stands at $606.9 million.
- Know Labs (AMEX:KNW) shares rose 54.86% to $0.79. The market value of their outstanding shares is at $5.9 million.
- Bluejay Diagnostics (NASDAQ:BJDX) shares rose 48.68% to $2.26. The market value of their outstanding shares is at $3.3 million.
- China SXT Pharmaceuticals (NASDAQ:SXTC) stock moved upwards by 39.16% to $1.86. The company's market cap stands at $48.5 million.
- BioSig Technologies (NASDAQ:BSGM) stock moved upwards by 38.76% to $7.96. The market value of their outstanding shares is at $217.4 million.
- NuCana (NASDAQ:NCNA) stock moved upwards by 29.87% to $0.05. As per the news, the Q1 earnings report came out 4 days ago.
Losers
- Vera Therapeutics (NASDAQ:VERA) shares fell 29.0% to $21.74 during Friday's regular session. The market value of their outstanding shares is at $1.3 billion.
- Scinai Immunotherapeutics (NASDAQ:SCNI) stock fell 24.62% to $2.45. The market value of their outstanding shares is at $2.2 million.
- Accuray (NASDAQ:ARAY) shares declined by 15.17% to $1.29. The market value of their outstanding shares is at $132.8 million.
- Cyclacel Pharmaceuticals (NASDAQ:CYCC) shares decreased by 15.1% to $0.51. The company's market cap stands at $12.2 million.
- Evoke Pharma (NASDAQ:EVOK) shares fell 13.4% to $3.0. The company's market cap stands at $4.4 million.
- Nuwellis (NASDAQ:NUWE) stock declined by 13.39% to $0.53. The market value of their outstanding shares is at $2.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.